Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma

Annals of Oncology, vol. 32, pp. 766–777

Authors 29

1. Robert V. Rawson

   The University of Sydney · Royal Prince Alfred Hospital · Melanoma Institute Australia · NSW Health Pathology

   Affiliation as printed

   Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia; NSW Health Pathology, Sydney, Australia

   Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia

   Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia

   Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

   Melanoma Institute Australia, The University of Sydney, Sydney, Australia

   NSW Health Pathology, Sydney, Australia

2. Carolien Bierman

   The Netherlands Cancer Institute

   Affiliation as printed

   The Netherlands Cancer Institute, Amsterdam, The Netherlands

3. Serigne Lo

   The University of Sydney · Melanoma Institute Australia

   Affiliation as printed

   Melanoma Institute Australia, The University of Sydney, Sydney, Australia

4. Elena Shklovskaya

   The University of Sydney · Melanoma Institute Australia · Macquarie University

   Affiliation as printed

   Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia

   Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia

   Melanoma Institute Australia, The University of Sydney, Sydney, Australia

5. Elisa A. Rozeman

   The Netherlands Cancer Institute

   Affiliation as printed

   The Netherlands Cancer Institute, Amsterdam, The Netherlands

6. Alexander Maxwell Menzies

   The University of Sydney · Royal North Shore Hospital · Melanoma Institute Australia

   Affiliation as printed

   Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia

   Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

   Mater Hospital, Sydney, Australia

   Melanoma Institute Australia, The University of Sydney, Sydney, Australia

   Royal North Shore Hospital, Sydney, Australia

7. Alexander C. J. van Akkooi

   The Netherlands Cancer Institute

   Affiliation as printed

   The Netherlands Cancer Institute, Amsterdam, The Netherlands

8. Kerwin Frank Shannon

   The University of Sydney · Royal Prince Alfred Hospital · Melanoma Institute Australia

   Affiliation as printed

   Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia

   Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia

   Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia

   Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

   Melanoma Institute Australia, The University of Sydney, Sydney, Australia

9. Maria Gonzalez

   The University of Sydney · Melanoma Institute Australia

   Affiliation as printed

   Melanoma Institute Australia, The University of Sydney, Sydney, Australia

10. Alexander David Guminski

    The University of Sydney · Royal North Shore Hospital · Melanoma Institute Australia

    Affiliation as printed

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia

    Mater Hospital, Sydney, Australia

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia

    Royal North Shore Hospital, Sydney, Australia

11. Mike T. Tetzlaff

    University of California, San Francisco

    Affiliation as printed

    Department of Pathology, Dermatopathology and Oral Pathology Unit, The University of California, San Francisco, San Francisco, USA; Department of Dermatology, Dermatopathology and Oral Pathology Unit, The University of California, San Francisco, San Francisco, USA

    Department of Dermatology, Dermatopathology and Oral Pathology Unit, The University of California, San Francisco, San Francisco, USA

    Department of Pathology, Dermatopathology and Oral Pathology Unit, The University of California, San Francisco, San Francisco, USA

12. Jonathan R. Stretch

    The University of Sydney · Royal Prince Alfred Hospital · Melanoma Institute Australia

    Affiliation as printed

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia

    Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia

    Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia

    Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

    Mater Hospital, Sydney, Australia

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia

13. Hanna Eriksson

    Karolinska University Hospital · Karolinska Institutet

    Affiliation as printed

    Theme Cancer, Skin Cancer Center/Department of Oncology, Karolinska University Hospital, Stockholm, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

    Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

    Theme Cancer, Skin Cancer Center/Department of Oncology, Karolinska University Hospital, Stockholm, Sweden

14. Johannes V. van Thienen

    The Netherlands Cancer Institute

    Affiliation as printed

    The Netherlands Cancer Institute, Amsterdam, The Netherlands

15. Michel W.J.M. Wouters Aachen Department of Biomedical Data Sciences

    Leiden University Medical Center · The Netherlands Cancer Institute

    Affiliation as printed

    The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands

    Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands

    The Netherlands Cancer Institute, Amsterdam, The Netherlands

16. John B.A.G. Haanen

    The Netherlands Cancer Institute

    Affiliation as printed

    The Netherlands Cancer Institute, Amsterdam, The Netherlands

17. W. Martin C. Klop

    The Netherlands Cancer Institute

    Affiliation as printed

    The Netherlands Cancer Institute, Amsterdam, The Netherlands

18. Charlotte L. Zuur

    The Netherlands Cancer Institute

    Affiliation as printed

    The Netherlands Cancer Institute, Amsterdam, The Netherlands

19. Winan J. van Houdt

    The Netherlands Cancer Institute

    Affiliation as printed

    The Netherlands Cancer Institute, Amsterdam, The Netherlands

20. Omgo E. Nieweg

    The University of Sydney · Royal Prince Alfred Hospital · Melanoma Institute Australia

    Affiliation as printed

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia

    Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia

    Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia

    Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

    Mater Hospital, Sydney, Australia

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia

21. Sydney Ch’ng

    The University of Sydney · Royal Prince Alfred Hospital · Melanoma Institute Australia

    Affiliation as printed

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia

    Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia

    Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia

    Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

    Mater Hospital, Sydney, Australia

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia

22. Helen Rizos

    The University of Sydney · Melanoma Institute Australia · Macquarie University

    Affiliation as printed

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia

    Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia

23. Robyn P.M. Saw

    The University of Sydney · Royal Prince Alfred Hospital · Melanoma Institute Australia

    Affiliation as printed

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia

    Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia

    Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia

    Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

    Mater Hospital, Sydney, Australia

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia

24. Andrew John Spillane

    The University of Sydney · Royal North Shore Hospital · Melanoma Institute Australia

    Affiliation as printed

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia

    Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

    Mater Hospital, Sydney, Australia

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia

    Royal North Shore Hospital, Sydney, Australia

25. James S. Wilmott

    The University of Sydney · Melanoma Institute Australia

    Affiliation as printed

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

    Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia

26. Christian U. Blank

    The Netherlands Cancer Institute

    Affiliation as printed

    The Netherlands Cancer Institute, Amsterdam, The Netherlands

27. Georgina Venetia Long

    The University of Sydney · Royal North Shore Hospital · Melanoma Institute Australia

    Affiliation as printed

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore Hospital, Sydney, Australia; Mater Hospital, Sydney, Australia

    Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

    Mater Hospital, Sydney, Australia

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia

    Royal North Shore Hospital, Sydney, Australia

28. Bart A. van de Wiel

    The Netherlands Cancer Institute

    Affiliation as printed

    The Netherlands Cancer Institute, Amsterdam, The Netherlands

29. Richard A. Scolyer corresponding

    The University of Sydney · Royal Prince Alfred Hospital · Melanoma Institute Australia · NSW Health Pathology

    Affiliation as printed

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia; Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia; NSW Health Pathology, Sydney, Australia. Electronic address: Richard.Scolyer@health.nsw.gov.au

    Department of Melanoma Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia

    Departments of Tissue Pathology and Diagnostic Oncology, Sydney, Australia

    Faculty of Medicine and Health, The University of Sydney, Sydney, Australia

    Melanoma Institute Australia, The University of Sydney, Sydney, Australia

    NSW Health Pathology, Sydney, Australia